noteworthy < novel < novo

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 68.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000011 (2020)	Binqing Fu ; Xiaoling Xu ; Haiming Wei	Why tocilizumab could be an effective treatment for severe COVID-19?
000020 (2020)	Jared Radbel [États-Unis] ; Navaneeth Narayanan [États-Unis] ; Pinki J. Bhatt [États-Unis]	Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: A cautionary case report.
000034 (2020)	Angelika Batta ; Bhupinder Singh Kalra ; Raj Khirasaria	Trends in FDA drug approvals over last 2 decades: An observational study
000042 (2020)	Prakhar Vijayvargiya [États-Unis] ; Zerelda Esquer Garrigos [États-Unis] ; Natalia E. Castillo Almeida [États-Unis] ; Pooja R. Gurram [États-Unis] ; Ryan W. Stevens [États-Unis] ; Raymund R. Razonable [États-Unis]	Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
000070 (2020)	Yasmine F. Ibrahim [Égypte] ; Rabab A. Moussa [Égypte] ; Asmaa M A. Bayoumi [Égypte] ; Al-Shaimaa F. Ahmed [Égypte]	Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein.
000077 (2020)	Lei Li [République populaire de Chine] ; Ranran Li [République populaire de Chine] ; Zhixiong Wu [République populaire de Chine] ; Xianghong Yang ; Mingyan Zhao [République populaire de Chine] ; Jiao Liu [République populaire de Chine] ; Dechang Chen [République populaire de Chine]	Therapeutic strategies for critically ill patients with COVID-19
000078 (2020)	Phulen Sarma ; Manisha Prajapat ; Pramod Avti ; Hardeep Kaur ; Subodh Kumar ; Bikash Medhi	Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
000085 (2020)	Ran Li ; Kunchi Zhao ; Qing Ruan ; Chunyang Meng ; Fei Yin	The transcription factor Foxd3 induces spinal cord ischemia-reperfusion injury by potentiating microRNA-214-dependent inhibition of Kcnk2
000090 (2020)	Muneyoshi Futami [Japon] ; Keisuke Suzuki [Japon] ; Satomi Kato [Japon] ; Saori Ohmae [Japon] ; Yoshio Tahara [Japon] ; Masanori Nojima [Japon] ; Yoichi Imai [Japon] ; Takayuki Mimura [Japon] ; Yoshihiro Watanabe [Japon] ; Arinobu Tojo [Japon]	The novel multi-cytokine inhibitor TO-207 specifically inhibits pro-inflammatory cytokine secretion in monocytes without affecting the killing ability of CAR T cells.
000097 (2020)	Weiyi Tan ; Jamil Aboulhosn	The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
000107 (2020)	Kyung Eun Kim ; Suwon Jeon ; Jisun Song ; Tae Sung Kim ; Min Kyung Jung ; Myun Soo Kim ; Sunyoung Park ; Seung Beom Park ; Jeong Min Park ; Hyun Jeong Park [Corée du Sud] ; Daeho Cho	The Novel Synthetic Peptide AESIS-1 Exerts a Preventive Effect on Collagen-Induced Arthritis Mouse Model via STAT3 Suppression
000131 (2020)	Waleed Alhazzani [Canada] ; Morten Hylander M Ller [Danemark] ; Yaseen M. Arabi ; Mark Loeb [Canada] ; Michelle Ng Gong [États-Unis] ; Eddy Fan [Canada] ; Simon Oczkowski [Canada] ; Mitchell M. Levy [États-Unis] ; Lennie Derde [Pays-Bas] ; Amy Dzierba [États-Unis] ; Bin Du [République populaire de Chine] ; Michael Aboodi [États-Unis] ; Hannah Wunsch ; Maurizio Cecconi [Italie] ; Younsuck Koh [Corée du Sud] ; Daniel S. Chertow [États-Unis] ; Kathryn Maitland [Royaume-Uni] ; Fayez Alshamsi [Émirats arabes unis] ; Emilie Belley-Cote [Canada] ; Massimiliano Greco [Italie] ; Matthew Laundy [Royaume-Uni] ; Jill S. Morgan [États-Unis] ; Jozef Kesecioglu [Pays-Bas] ; Allison Mcgeer [Canada] ; Leonard Mermel [États-Unis] ; Manoj J. Mammen [États-Unis] ; Paul E. Alexander [Canada] ; Amy Arrington [États-Unis] ; John E. Centofanti [Canada] ; Giuseppe Citerio [Italie] ; Bandar Baw [Canada, Arabie saoudite] ; Ziad A. Memish ; Naomi Hammond [Australie] ; Frederick G. Hayden [États-Unis] ; Laura Evans [États-Unis] ; Andrew Rhodes [Royaume-Uni]	Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
000167 (2020)	Peter A. Riedell ; Michael R. Bishop	Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas
000168 (2020)	Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Sakae Tanaka [Japon] ; Atsushi Kawakami [Japon] ; Yeong-Wook Song [Corée du Sud] ; Yi-Hsing Chen [Taïwan] ; Mitsuhiro Rokuda [Japon] ; Hiroyuki Izutsu [Japon] ; Satoshi Ushijima [Japon] ; Yuichiro Kaneko [Japon] ; Yoshihiro Nakashima [Japon] ; Teruaki Shiomi [Japon] ; Emi Yamada [Japon]	Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan
000171 (2020)	Hongyan Qi [République populaire de Chine] ; Zhiyi Yang [République populaire de Chine] ; Chujun Dai [République populaire de Chine] ; Runan Wang [République populaire de Chine] ; Xinxin Ke [République populaire de Chine] ; Shuilian Zhang [République populaire de Chine] ; Xueping Xiang [République populaire de Chine] ; Kailin Chen [République populaire de Chine] ; Chen Li [République populaire de Chine] ; Jindan Luo [République populaire de Chine] ; Jimin Shao [République populaire de Chine] ; Jing Shen [République populaire de Chine]	STAT3 activates MSK1-mediated histone H3 phosphorylation to promote NFAT signaling in gastric carcinogenesis
000193 (2020)	Ka-Tim Choy [République populaire de Chine] ; Alvina Yin-Lam Wong [République populaire de Chine] ; Prathanporn Kaewpreedee [République populaire de Chine] ; Sin Fun Sia [République populaire de Chine] ; Dongdong Chen [République populaire de Chine] ; Kenrie Pui Yan Hui [République populaire de Chine] ; Daniel Ka Wing Chu [République populaire de Chine] ; Michael Chi Wai Chan [République populaire de Chine] ; Peter Pak-Hang Cheung [République populaire de Chine] ; Xuhui Huang [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Hui-Ling Yen [République populaire de Chine]	Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
000199 (2020)	Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis]	Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
000206 (2020)	Christos Koutsianas ; Konstantinos Thomas ; Dimitrios Vassilopoulos	Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
000207 (2020)	Shengyu Zhang ; Lei Li ; Aizong Shen ; Yongwu Chen ; Zhigang Qi	Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
000221 (2020)	Yao-Chung Liu [Taïwan] ; Ting-An Lin [Taïwan] ; Hao-Yuan Wang [Taïwan] ; Po-Shen Ko [Taïwan] ; Chia-Jen Liu [Taïwan] ; Liang-Tsai Hsiao [Taïwan] ; Sheng-Hsuan Chien [Taïwan] ; Jyh-Pyng Gau [Taïwan]	Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report
000227 (2020)	Lauren E. Lee [États-Unis] ; Bradley W. Beeler [États-Unis] ; Brendan C. Graham [États-Unis] ; Andrew P. Cap [États-Unis] ; Nay Win [Royaume-Uni] ; Frederick Chen [Royaume-Uni]	Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "novel" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "novel" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    novel
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021